Soft tissue sarcomas (STS) are a diverse group of malignant tumors that occur throughout the soft tissues. Although rare, these sarcomas account for more than 12,000 new cases annually in the United States. The possibility of a sarcoma must be considered in the differential diagnosis of any suspicious mass.
This CME activity provides guidance through the initial diagnostic workup and reviews the latest data of new and emerging therapeutic options for advanced, metastatic STS. For best results, community-based oncologists are encouraged to partner with an academic center specializing in the management of sarcoma. These multidisciplinary teams, together with the community oncologist, can optimize treatment outcomes for their patients with STS.
|Available Credit:||0.75 AMA PRA Category 1 Credit™.|
|Opens:||July 31, 2018|
|Expires:||July 30, 2019|
Other Healthcare Providers